AcquisitionOther
Aeglea BioTherapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Aeglea BioTherapeutics, Inc. -> target · $210 million
Industry Information This presentation also contains or references certain industry data that is based upon information from independent industry publications, market research, and surveys and other publicly available sources.
Open source record (SEC) ↗